​
​

Estrella Immunopharma Ownership 2024 | Who Owns Estrella Immunopharma Now?

OverviewFinancialsChart

Institutional Ownership

20.11%

Insider Ownership

59.20%

Retail Ownership

20.69%

Institutional Holders

3.00

Estrella Immunopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OWL CREEK ASSET MANAGEMENT, L.P.----255,000-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----20,505-100.00%-Dec 31, 2023
MASO CAPITAL PARTNERS LTD----10,000-100.00%-Dec 31, 2023

Estrella Immunopharma's largest institutional shareholder is OWL CREEK ASSET MANAGEMENT, L.P., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OWL CREEK ASSET MANAGEMENT, L.P.----255,000-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----20,505-100.00%-Dec 31, 2023
MASO CAPITAL PARTNERS LTD----10,000-100.00%-Dec 31, 2023

The largest Estrella Immunopharma shareholder by % of total assets is OWL CREEK ASSET MANAGEMENT, L.P.. The company owns 0.00 shares of Estrella Immunopharma (UPTD), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MASO CAPITAL PARTNERS LTD----10,000-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----20,505-100.00%-Dec 31, 2023
OWL CREEK ASSET MANAGEMENT, L.P.----255,000-100.00%-Dec 31, 2023

As of Dec 31 2023, Estrella Immunopharma's largest institutional buyer is MASO CAPITAL PARTNERS LTD. The company purchased -10.00K stocks of UPTD, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OWL CREEK ASSET MANAGEMENT, L.P.----255,000-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----20,505-100.00%-Dec 31, 2023
MASO CAPITAL PARTNERS LTD----10,000-100.00%-Dec 31, 2023

As of Dec 31 2023, Estrella Immunopharma's biggest institutional seller is OWL CREEK ASSET MANAGEMENT, L.P.. The company sold -0.26M shares of UPTD, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OWL CREEK ASSET MANAGEMENT, L.P.----255,000-100.00%-Dec 31, 2023
JANE STREET GROUP, LLC----20,505-100.00%-Dec 31, 2023
MASO CAPITAL PARTNERS LTD----10,000-100.00%-Dec 31, 2023

Estrella Immunopharma's largest sold out institutional shareholder by shares sold is OWL CREEK ASSET MANAGEMENT, L.P., sold -0.26M shares, valued at -, as of undefined.

Estrella Immunopharma Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
Investment Managers Series Trust0.00%12,610--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%1,582--Feb 29, 2024

Estrella Immunopharma's largest mutual fund holder by % of total assets is "Investment Managers Series Trust", owning 12.61K shares, compromising 0.00% of its total assets.

Estrella Immunopharma Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 233-66.67%
30 Jun, 23912.50%
31 Mar, 238-38.46%
31 Dec, 2213-40.91%
30 Sep, 22224.76%
30 Jun, 22215.00%
31 Mar, 222011.11%
31 Dec, 211820.00%
30 Sep, 2115-

As of 30 Sep 23, 3 institutions are holding Estrella Immunopharma's shares, representing a decrease of -66.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 23285,505-62.18%
30 Jun, 23754,983-1.21%
31 Mar, 23764,251-60.20%
31 Dec, 221,920,170-40.61%
30 Sep, 223,233,4180.61%
30 Jun, 223,213,7943.16%
31 Mar, 223,115,2360.71%
31 Dec, 213,093,25013.42%
30 Sep, 212,727,288-

Estrella Immunopharma (UPTD) has 285.50K shares outstanding as of 30 Sep 23, down -62.18% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 2320.11%0.71%
30 Jun, 2353.18%1.84%
31 Mar, 2353.83%0.29%
31 Dec, 22135.25%0.26%
30 Sep, 22227.75%0.44%
30 Jun, 22226.37%0.47%
31 Mar, 22219.43%0.32%
31 Dec, 21262.29%0.58%
30 Sep, 21213.06%-

As of 30 Sep 23, Estrella Immunopharma is held by 20.11% institutional shareholders, representing a 0.71% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 232-
30 Jun, 232-33.33%
31 Mar, 233-57.14%
31 Dec, 227-
30 Sep, 227250.00%
30 Jun, 222-33.33%
31 Mar, 223-70.00%
31 Dec, 2110-33.33%
30 Sep, 2115-

2 institutional shareholders have increased their position in UPTD stock as of 30 Sep 23 compared to 2 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 23--100.00%
30 Jun, 232100.00%
31 Mar, 231-66.67%
31 Dec, 223200.00%
30 Sep, 221-50.00%
30 Jun, 222-
31 Mar, 222-
31 Dec, 21--
30 Sep, 21--

- institutional shareholders have reduced their position in UPTD stock as of 30 Sep 23 compared to 2 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 233-66.67%285,505-62.18%20.11%0.71%2---100.00%
30 Jun, 23912.50%754,983-1.21%53.18%1.84%2-33.33%2100.00%
31 Mar, 238-38.46%764,251-60.20%53.83%0.29%3-57.14%1-66.67%
31 Dec, 2213-40.91%1,920,170-40.61%135.25%0.26%7-3200.00%
30 Sep, 22224.76%3,233,4180.61%227.75%0.44%7250.00%1-50.00%
30 Jun, 22215.00%3,213,7943.16%226.37%0.47%2-33.33%2-
31 Mar, 222011.11%3,115,2360.71%219.43%0.32%3-70.00%2-
31 Dec, 211820.00%3,093,25013.42%262.29%0.58%10-33.33%--
30 Sep, 2115-2,727,288-213.06%-15---

Estrella Immunopharma Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 10, 2023Xu Jiandongofficer Chief Financial OfficerSell---264,388
Oct 10, 2023Liu Chengdirector, officer Chief Executive OfficerSell---297,437
Oct 10, 2023Eureka Therapeutics, Inc.10 percent owner-Sell---25,277,831
Oct 05, 2023Owl Creek Asset Management, L.P.10 percent owner-J-OtherSell255,000$10.86$2.77M-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 10, 2023Xu Jiandongofficer Chief Financial OfficerSell---264,388
Oct 10, 2023Roberts Marshadirector Buy----
Oct 10, 2023Xu Peidirector Buy----
Oct 10, 2023Liu Chengdirector, officer Chief Executive OfficerSell---297,437
Oct 10, 2023Wu Xuejun Janelledirector Buy----
Oct 10, 2023Wu Fandirector Buy----
Oct 10, 2023Eureka Therapeutics, Inc.10 percent owner-Sell---25,277,831
Oct 05, 2023Owl Creek Asset Management, L.P.10 percent owner-J-OtherSell255,000$10.86$2.77M-
Oct 02, 2023TradeUP Acquisition Sponsor LLC-Buy----
Oct 02, 2023Long James-Buy----
Oct 02, 2023Jiang Tao-Buy----
Oct 02, 2023Wen Luqi-Buy----
Oct 02, 2023Li Jianwei-Buy----
Oct 02, 2023Twigg Weston-Buy----
Oct 02, 2023Yang Weiguang-Buy----
Jan 09, 2023Owl Creek Asset Management, L.P.director-Buy---255,000
Mar 17, 2022Li Jianweiofficer Co-Chief Executive OfficerP-PurchaseBuy141,970$314.70K$44.68B1,253,730

The last insider sell of Estrella Immunopharma's stock was made by Xu Jiandong on Oct 10 2023, selling - shares at - per share (valued at -). The last insider buy of UPTD was made by Li Jianwei on Mar 17 2022, buying 141,970 shares at $314.70K per share (worth $44.68B).

Estrella Immunopharma Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2023---
Q1 20221--

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Estrella Immunopharma's insiders, as of Q1 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2023---
Q1 20221--

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Estrella Immunopharma's stocks.

Estrella Immunopharma Peer Ownership

TickerCompany
DTOCAmerican Oncology Network, Inc.
PNACPrime Number Acquisition I Corp.
LGVCLAMF Global Ventures Corp. I
LBBBLakeshore Acquisition II Corp.
ITAQIndustrial Tech Acquisitions II, Inc.
FLFVFeutune Light Acquisition Corporation
BHACCrixus BH3 Acquisition Company
CPAAAdvantage Solutions Inc.
BLACBellevue Life Sciences Acquisition Corp.

UPTD Ownership FAQ

Estrella Immunopharma is owned by institutional shareholders (20.11%), insiders (59.20%), and public (20.69%). The largest institutional shareholder of Estrella Immunopharma is OWL CREEK ASSET MANAGEMENT, L.P. (0% of total shares) and the top mutual fund owner is Investment Managers Series Trust (0.00% of total shares).

Estrella Immunopharma's major institutional shareholders are OWL CREEK ASSET MANAGEMENT, L.P., JANE STREET GROUP, LLC, and MASO CAPITAL PARTNERS LTD. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 3 institutional shareholders of Estrella Immunopharma.

OWL CREEK ASSET MANAGEMENT, L.P owns 0 shares of Estrella Immunopharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, JANE STREET GROUP, LLC holds 0 shares of Estrella Immunopharma (UPTD), compromising 0% of the company, valued at $0.

MASO CAPITAL PARTNERS LTD is the third largest holder of Estrella Immunopharma. The company owns 0 of the company's shares outstanding (worth $0).